https://nl.marketscreener.com/koers/aandeel/2SEVENTY-BIO-INC-128358117/nieuws/FDA-Advisory-Committee-stemt-voor-Bristol-Myers-Squibb-Company-en-2seventy-bio-Inc-Abecma-voor-Tri-46215560/?utm_source=telegram&utm_medium=social&utm_campaign=share